4//SEC Filing
Smith Bryan E. 4
Accession 0000950170-25-004921
CIK 0001404281other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:30 PM ET
Size
8.6 KB
Accession
0000950170-25-004921
Insider Transaction Report
Form 4
Smith Bryan E.
General Counsel, Corporate Sec
Transactions
- Award
Stock Option (right to buy)
2025-01-10+150,500→ 150,500 totalExercise: $4.04Exp: 2035-01-10→ Common Stock (150,500 underlying) - Award
Restricted Stock Units
2025-01-10+64,500→ 64,500 total→ Common Stock (64,500 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase up to 150,000 shares of common stock, which option vests with respect to 37,625 shares on January 10, 2026, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending January 10, 2029, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
- [F2]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
- [F3]Represents shares issuable on settlement of restricted stock units ("RSUs"). The RSUs will vest with respect to 50% of the RSUs on January 10, 2027, and then with respect to the remaining 50% of the underlying shares on January 10 2028, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
Documents
Issuer
Eledon Pharmaceuticals, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001748041
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:30 PM ET
- Size
- 8.6 KB